help@researchreport.co.uk

Psoriasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2028

  • Report ID : 100317
  • Category : Pharmaceuticals
  • Pages : -----
  • Reporting status : Published Jan, 19
Allows one Individual to access the Report within an organization
Allows all Employee to access the Report within an organization

Please choose the suitable license type from above.

Buy Now
  • Description
  • Table of Content
  • Research Methodology
  • Related Reports

Psoriasis is non-communicable autoimmune inflammatory, chronic, and painful skin disease characterized by abnormal skin patches. These skin patches are scaly, red, and itchy. These patches may be small and either localized or encompass the entire body. At present, there is no cure for this disease and the major  goal of treatment is to limit inflammation and formation of abnormal skin plaque. Factors such as rising disease prevalence, significant unmet needs, and large number of pipeline molecules would drive the psoriasis treatment market growth across the globe.

There are five different psoriasis types namely Inverse, Plaque, Pustular, and Erythrodermic. The most common type of psoriasis is called Plaque psoriasis or psoriasis vulgaris, and accounts for over 90% of reported cases. The majorly affected body areas include around the navel, back of the forearms, shins, and the scalp. The guttate psoriasis is characterized by drop-shaped lesions while in pustular psoriasis small non-infectious pus-filled blisters are seen. Inverse psoriasis leads to the formation of red patches in skin folds. Erythrodermic psoriasis occurs on widespreading of the rash and develops into other types. At some point of disease, the fingernails and toenails are affected in most people. This may include nails pits or lead to transformation in nail color.

Factors promoting the growth of psoriasis market include availability of varied treatment options for psoriasis, use of light therapy for psoriasis and rising prevalence of psoriasis coupled with early diagnosis.

 Different treatment methods can aid to control the psoriasis symptoms that is fuelling its treatment market growth. The different treatment methods include administration of steroid, vitamin D3, exposure to ultraviolet B (UVB) light, and immunosuppressive like methotrexate. Over 75% of the cases can be treated with creams alone. Cream and ointments of corticosteroid, and calcipotriol can help to treat mild-to-moderate psoriasis. However, in cases of severe psoriasis, creams are coupled along with oral medications such as methotrexate, acitretin, and cyclosporin.

Various topical drugs that are used in psoriasis treatment include hydroxyanthrone, corticosteroids, vitamin D, and retinoid. For the treatment of mild-to-moderate psoriasis, topical corticosteroids are often prescribed. However, low-potency corticosteroid ointments can be used for sensitive areas such as face or skin folds and for the treatment of widespread damaged skin patches. Medicated foams as well as scalp solutions are available in market for the treatment of psoriasis scalp patches.

The global psoriasis treatment market can be classified based on drug class, route of administration and region. On the basis of drug class, the global market is classified into TNF inhibitors, vitamin D analogues, interleukin blockers, topical corticosteroids and others. Further based upon route of administration, it is segmented into topical therapeutic, oral therapeutic,and parenteral therapeutic drugs.

Based on regions, the global psoriasis treatment market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the psoriasis treatment market during the forecast period. Factors such as large patient pool, better medical facilities, commercialization of new diagnostic technology, medical policies, and favorable reimbursement policies are fuelling the growth of this market.

The major companies that provide psoriasis treatment include Johnson & Johnson, Glenmark Pharmaceuticals Limited, Cipla Ltd., Sun Pharmaceuticals Industries Ltd., Stiefel Laboratories Inc. (GlaxoSmithKline plc), Win Medicare Pvt. Ltd., Rowan Bioceuticals Private Limited, and Novartis AG.

Want to customize this report?

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.


Please Fill In The Customization Form With Your Requirements.


Help Center

Email Address : help@researchreport.co.uk

Help Center

Toll Free :+442037693786

More FAQ's